Bacterial enzymes and proteins

Bacterial enzymes and proteins encompass the vast array of molecular machinery produced by bacteria that facilitate essential life processes such as metabolism, replication, and structural integrity. In the context of pharmacology, these molecules serve as the primary targets for antibiotic and antibacterial therapies. For example, beta-lactams target penicillin-binding proteins (PBPs) to disrupt cell wall synthesis, while fluoroquinolones inhibit DNA gyrase and topoisomerase IV to prevent DNA replication (Source: StatPearls, "Antibiotics", 2023). Additionally, the bacterial ribosome is a major target for protein synthesis inhibitors like macrolides and aminoglycosides (Source: NIH, "Mechanism of Action of Antibacterial Agents", 2021). Because this term encompasses thousands of distinct proteins across diverse bacterial species, it is considered a broad category rather than a specific therapeutic target. Effective drug development requires identifying specific, conserved, or unique bacterial proteins that can be selectively inhibited without affecting human orthologs to minimize side effects and combat the growing threat of antimicrobial resistance (Source: WHO, "Antimicrobial Resistance", 2021).

Other names

Bacterial proteomeMicrobial proteinsProkaryotic enzymesBacterial drug targets

Antibacterial drugs target these proteins to inhibit cell wall synthesis, disrupt cell membrane integrity, inhibit protein synthesis, interfere with nucleic acid synthesis, or block essential metabolic pathways (Source: NIH, "Mechanism of Action of Antibacterial Agents", 2021).